An experimental COVID-19 treatment pill, called molnupiravir and being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP. (Photo by Merck & Co Inc/Handout via REUTERS)

COVID-19 pill may revive old, bitter debate

Common sense, whether it’s humanitarian or economic, dictates that if the world has found a drug that can make the coronavirus a lot less scary, the treatment should be made…

Read More

CCSA approves plan to buy 50,000 courses of anti-viral Molnupiravir drug

Thailand’s Centre for COVID-19 Situation Administration (CCSA) today (Thursday) approved the Public Health Ministry’s proposal to procure 50,000 courses of the anti-viral Molnupiravir drug, made by US pharmaceutical company Merck. …

Read More

Thailand to import 200,000 courses of Molnupiravir anti-viral drug from USA

The Ministry of Public Health is to seek approval from the Thai cabinet for the procurement of 200,000 courses of the Molnupiravir oral anti-viral medicine, using money from the Central…

Read More

Page 1 of 1

Login

Welcome! Login in to your account

Remember me Lost your password?

Lost Password